Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Daniel Loeb Tells Amgen to Split

Amgen

Daniel Loeb, manger of Third Point, is one of Amgen‘s largest shareholders, and is telling it to split up the company into one that focuses on legacy drugs and another segment that places emphasis on the pipeline, according to DealPipeline. Loeb wasn’t the first one to have this idea; Analyst Geoffrey Porges of Sanford Bernstein suggested it, but Loeb has a significant share of the company and can make some noise about the proposed breakup. He believes the spin-off will remedy some complaints on Wall Street about Amgen, namely, that it wasn’t focusing enough on research and development, had flat operating margins and was delaying a buyback so it could pay $9 billion for Onyx. In addition, Loeb doesn’t think Wall Street sufficiently appreciates the potential of some of its innovative drugs, such as evolocumab, its treatment for dyslipidemia.

Loeb expects the shareholders to discuss the option of splitting up at a meeting on October 28. Loeb said CEO Bob Bradway has been open minded about the possibility for a spin-off.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.

Amgen isn’t the only company Loeb wants to put through a divorce proceeding. As a shareholder if eBay, he was happy to see it split off Paypal. Loeb means business when it comes to throwing his activist weight around; he sold his shares of Sony, even though the company showed improvement, because management refused to follow his advice and spin off 15-20% of its American entertainment business. He has also tried to persuade Dow Chemical to separate its petrochemical business from its regular chemicals.

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.